CHIGENOVO

Beijing, China · Founded 2016 · Privately Held (backing)

Developer of clinical genetic diagnosis, fertility prevention and gene therapy drug for hereditary eye diseases. CHIGENOVO is based in Beijing, China and was founded in 2016. Its last reported valuation was $110 million in Mar 2022. It has raised $41 million.

Last reported valuation

$110.4M

Oct 2026

Priced at

—

Total raised

$41.0M

Last round

—

How much has CHIGENOVO raised?

$41.0Macross 0 recorded rounds

Free account

More of CHIGENOVO with a free account

·Watch CHIGENOVO: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

CHIGENOVO investors

10 investors are on record for CHIGENOVO, including Cowin Capital, Puhua Capital, Lapam Capital and Lotus Lake Ventures. By type, the record holds 4 venture capital firms, 1 family office and 1 growth equity firm.

For fundraisers

Raising for a company like CHIGENOVO?

10 investors have backed CHIGENOVO.

See all 10 investors →

Frequently asked about CHIGENOVO

How much has CHIGENOVO raised?: CHIGENOVO has raised $41.0M in total across 0 recorded funding rounds.